AXSM
Axsome Therapeutics Inc
NASDAQ: AXSM · HEALTHCARE · BIOTECHNOLOGY
$183.95
-0.57% today
Updated 2026-04-29
Market cap
$9.46B
P/E ratio
—
P/S ratio
14.82x
EPS (TTM)
$-3.68
Dividend yield
—
52W range
$96 – $193
Volume
0.6M
Axsome Therapeutics Inc (AXSM) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $8.82M | $50.04M | $270.60M | $385.69M | $638.50M |
| Revenue growth (YoY) | — | — | — | — | — | — | — | — | — | +467.3% | +440.8% | +42.5% | +65.5% |
| Cost of revenue | — | $0.00 | $3542.00 | $20484.00 | $42557.00 | $48935.00 | $37330.00 | $77718.00 | $1.16M | $5.20M | $26.07M | $33.30M | $47.48M |
| Gross profit | — | $0.00 | $-3542.00 | $-20484.00 | $-42557.00 | $-48935.00 | $-37330.00 | $-77718.00 | $-1.16M | $44.84M | $244.53M | $352.39M | $591.02M |
| Gross margin | — | — | — | — | — | — | — | — | -13.1% | 89.6% | 90.4% | 91.4% | 92.6% |
| R&D | $1.54M | $4.28M | $6.78M | $21.20M | $19.96M | $23.50M | $53.65M | $70.24M | $58.06M | $57.95M | $97.94M | $187.08M | $183.28M |
| SG&A | $304183.00 | $1.39M | $2.42M | $6.34M | $7.21M | $9.35M | $13.60M | $28.90M | $66.65M | $123.95M | $222.82M | $310.16M | $570.60M |
| Operating income | $-1.84M | $-5.67M | $-9.20M | $-27.54M | $-27.16M | $-32.85M | $-67.25M | $-99.14M | $-124.71M | $-179.80M | $-231.82M | $-280.56M | $-169.24M |
| Operating margin | — | — | — | — | — | — | — | — | -1413.9% | -359.3% | -85.7% | -72.7% | -26.5% |
| EBITDA | $-1.84M | $-2.74M | $-9.19M | $-27.52M | $-27.77M | $-32.58M | $-67.21M | $-100.31M | $-123.55M | $-175.40M | $-224.99M | $-272.60M | $-168.08M |
| EBITDA margin | — | — | — | — | — | — | — | — | -1400.8% | -350.5% | -83.1% | -70.7% | -26.3% |
| EBIT | $-1.84M | $-5.67M | $-9.20M | $-27.54M | $-27.81M | $-32.63M | $-67.25M | $-100.39M | $-124.71M | $-179.80M | $-231.82M | $-280.56M | $-177.15M |
| Interest expense | $327192.00 | $2.23M | $914952.00 | $132424.00 | $1.34M | $1.13M | $1.24M | $2.57M | $5.70M | $7.33M | $6.45M | $6.57M | $6.56M |
| Income tax | $-1.84M | $-2.42M | $1.36M | $586219.00 | $1.30M | $3.01M | $1.34M | $2.49M | $4.54M | $10.63M | $960000.00 | $85000.00 | — |
| Effective tax rate | 45.9% | 28.7% | -12.5% | -2.2% | -4.7% | -10.8% | -2.0% | -2.5% | -3.5% | -6.0% | -0.4% | -0.0% | 0.0% |
| Net income | $-2.17M | $-6.00M | $-12.21M | $-27.20M | $-28.94M | $-30.97M | $-68.35M | $-102.90M | $-134.94M | $-187.13M | $-239.24M | $-287.22M | $-183.17M |
| Net income growth (YoY) | — | -177.0% | -103.5% | -122.8% | -6.4% | -7.0% | -120.7% | -50.6% | -31.1% | -38.7% | -27.8% | -20.1% | +36.2% |
| Profit margin | — | — | — | — | — | — | — | — | -1530.0% | -374.0% | -88.4% | -74.5% | -28.7% |